Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.16
-0.0550-1.71%
Post-market: 3.170.0100+0.32%18:09 EDT
Volume:10.62M
Turnover:33.75M
Market Cap:1.69B
PE:-3.09
High:3.25
Open:3.14
Low:3.10
Close:3.22
52wk High:7.18
52wk Low:2.77
Shares:535.00M
Float Shares:522.33M
Volume Ratio:0.62
T/O Rate:2.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0219
EPS(LYR):-1.4410
ROE:-56.58%
ROA:-27.33%
PB:1.85
PE(LYR):-2.19

Loading ...

Dec 04, 2024

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS, INC.'s Officer Gibson Christopher proposes to sell 20000 Shares, with a total value of approximately $143,200.
Dec 03, 2024

Major Issues Report

Form 8-K - Current report
Nov 27, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 26, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 04, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities